acebutolol has been researched along with Glycogen Storage Disease Type II in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Vries, JM; Goudriaan, DA; Huijmans, JG; Reuser, AJ; Ruijter, GJ; Sluiter, W; van den Bosch, JC; van der Ploeg, AT; van Gelder, CM | 1 |
| Blanco, M; Casentini, C; Chamoles, NA; Gaggioli, D; Niizawa, G | 1 |
| Bali, D; Carr, C; Chen, YT; Dai, J; Kallwass, H; Keutzer, J; Kishnani, PS; Millington, DS; Young, SP; Zhang, H | 1 |
| Carey, WF; Nelson, PV; Pollard, AC | 1 |
| Beratis, NG; Hirschhorn, K; LaBadie, GU | 1 |
| Chen, YT; Kay, HH; Lanman, J; McConkie-Rosell, A; Park, HK | 1 |
6 other study(ies) available for acebutolol and Glycogen Storage Disease Type II
| Article | Year |
|---|---|
Rapid ultraperformance liquid chromatography-tandem mass spectrometry assay for a characteristic glycogen-derived tetrasaccharide in Pompe disease and other glycogen storage diseases.
Topics: Adolescent; Adult; Age Factors; Aged; Child; Child, Preschool; Chromatography, Liquid; Glycogen; Glycogen Storage Disease; Glycogen Storage Disease Type II; Glycogen Storage Disease Type III; Glycogen Storage Disease Type IV; Humans; Infant; Infant, Newborn; Maltose; Middle Aged; Oligosaccharides; Reference Values; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Young Adult | 2012 |
Glycogen storage disease type II: enzymatic screening in dried blood spots on filter paper.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Buffers; Child; Child, Preschool; Diagnosis, Differential; Female; Filtration; Glucan 1,4-alpha-Glucosidase; Glycogen Storage Disease Type II; Glycoside Hydrolase Inhibitors; Humans; Hydrogen-Ion Concentration; Indicators and Reagents; Infant; Infant, Newborn; Male; Maltose; Middle Aged; Neonatal Screening; Paper; Specimen Handling | 2004 |
Comparison of maltose and acarbose as inhibitors of maltase-glucoamylase activity in assaying acid alpha-glucosidase activity in dried blood spots for the diagnosis of infantile Pompe disease.
Topics: Acarbose; Adult; alpha-Glucosidases; Clinical Enzyme Tests; Enzyme Inhibitors; Glycogen Storage Disease Type II; Glycoside Hydrolase Inhibitors; Heterozygote; Humans; Hydrogen-Ion Concentration; Infant, Newborn; Maltose | 2006 |
A micro-radiochemical assay for alpha-1,4-glucosidase and its use in the assessment of type II glycogenosis (Pompe's disease).
Topics: Amnion; Cell Line; Clinical Enzyme Tests; Fibroblasts; Glucosidases; Glycogen Storage Disease; Glycogen Storage Disease Type II; Humans; Hydrogen-Ion Concentration; Leukocytes; Maltose; Time Factors | 1977 |
Characterization of the molecular defect in infantile and adult acid alpha-glucosidase deficiency fibroblasts.
Topics: Adult; alpha-Glucosidases; Antibody Formation; Cross Reactions; Electrophoresis, Polyacrylamide Gel; Electrophoresis, Starch Gel; Female; Fibroblasts; Genes; Glucosidases; Glycogen Storage Disease; Glycogen Storage Disease Type II; Humans; Hydrogen-Ion Concentration; Immunodiffusion; Infant; Male; Maltose; Mutation; Placenta; Pregnancy; Skin | 1978 |
Prenatal diagnosis of Pompe's disease (type II glycogenosis) in chorionic villus biopsy using maltose as a substrate.
Topics: alpha-Glucosidases; Chorionic Villi Sampling; Female; Glycogen Storage Disease Type II; Humans; Hydrogen-Ion Concentration; Maltose; Pregnancy; Pregnancy Trimester, First; Time Factors | 1992 |